This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Argenx Bv. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Marie Godar - Innovator in Chronic Airway Disease Treatment
Introduction
Marie Godar is a prominent inventor based in Ghent, Belgium. She has made significant contributions to the field of medicine, particularly in the treatment of chronic airway diseases such as asthma. Her innovative work focuses on developing combination therapies that target specific receptors involved in these conditions.
Latest Patents
Marie Godar holds a patent for "Multispecific antibodies against IL-5 and IL-4R." This invention relates to combination therapies that utilize an antagonist of IL-5:IL-5R and an antagonist of IL-4:IL-4R and/or an antagonist of IL-13:IL-13R. The patent also includes bispecific antibodies that bind to IL-4Rα and IL-5, which can be used for treating chronic airway diseases, particularly asthma.
Career Highlights
Marie is associated with Argenx Bv, a company known for its innovative approaches in the field of biotechnology. Her work has been instrumental in advancing therapeutic options for patients suffering from chronic airway diseases.
Collaborations
Marie collaborates with notable colleagues such as Christophe Blanchetot and Bart Lambrecht, contributing to a dynamic research environment that fosters innovation and development in medical therapies.
Conclusion
Marie Godar's contributions to the field of chronic airway disease treatment through her innovative patents and collaborations highlight her role as a leading inventor in biotechnology. Her work continues to pave the way for new therapeutic strategies that can significantly improve patient outcomes.